When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Vaxart (NASDAQ: VXRT) recently reported preliminary results from phase 1 study of its tablet COVID-19 vaccine candidate. Although there were some positive data in those results, many investors worried about the failure of the experimental vaccine to produce neutralizing antibodies in study participants. The biotech stock plunged after the clinical update. In this Motley Fool Live video recorded on Feb. 3, 2021 , Fool.com contributors Keith Speights and Brian Orelli answer a viewer's question about whether Vaxart still has a future.